USPTO serial 88371689
UNICELL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FALK, ERIN
- Law office
- TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with UNICELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Minato-ku, Tokyo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. SCOTT ALPRIN ALPRIN LAW OFFICES, P.C.5 PINEHURST CIRCLE, N.W.WASHINGTON, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; Stem cells for scientific purposes; stem cells, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Biological tissue cultures, other than for medical or veterinary purposes; Biological preparation for use in cell cultures other than for medical or veterinary use; Biological preparations, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Cells for medical or clinical use; Cell preparation for treatment of diseases; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprising living tissue grown from stem cells; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Biological preparations for the treatment of ophthalmic, central nervous, respiratory, or cardiovascular disease; Biological preparations for veterinary purposes; Diagnostic preparations for medical and veterinary use; Diagnostic reagents for medicinal use; Veterinary diagnostic reagents; Adjuvants for medical purposes; Cytostatics for medical purposes; Pharmaceutical preparations for activating cellular function; Sanitary preparations for medical use; Ophthalmic preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for ocular or intraocular surgery; Collyrium; Eye drops; Pharmaceutical agents affecting the central nervous system; Pharmaceutical preparations for the peripheral nervous system; Cardiovascular agents for medical purposes; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Cardiovascular pharmaceutical preparations; Respiratory stimulants; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Anti-inflammatories; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents for treating physically caused lesions; Opotherapy preparations; Organotherapy preparations; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Surgical implants comprised of living tissues; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for use in the fields of anesthesia, oncology, urology and gynecology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 15, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 2, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2019 | NWAP | NEW APPLICATION ENTERED | — |